MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
MDGL Madrigal Pharmaceuticals
- 308.440
- +15.030+5.12%
Close Dec 20 16:00 ET
- 308.440
- -0.0010.00%
Post 20:05 ET
6.73BMarket Cap-12.32P/E (TTM)
312.520High293.000Low716.86KVolume294.000Open293.410Pre Close218.94MTurnover6.83%Turnover RatioLossP/E (Static)21.81MShares368.29052wk High8.66P/B3.24BFloat Cap168.24652wk Low--Dividend TTM10.49MShs Float415.800Historical High--Div YieldTTM6.65%Amplitude6.600Historical Low305.413Avg Price1Lot Size
Madrigal Pharmaceuticals Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 22, 2024
The average Madrigal Pharmaceuticals stock price target is 391.60 with a max estimate of 441.00 and a min estimate of 336.00
Review Madrigal Pharmaceuticals earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 22, 2024